Kubota, R.; Hanada, K.; Saito, M.; Dozono, M.; Nozuma, S.; Takashima, H.
High TCR Degeneracy Enhances Antiviral Efficacy of HTLV-1-Specific CTLs by Targeting Variant Viruses in HAM Patients. Int. J. Mol. Sci. 2025, 26, 6602.
https://doi.org/10.3390/ijms26146602
AMA Style
Kubota R, Hanada K, Saito M, Dozono M, Nozuma S, Takashima H.
High TCR Degeneracy Enhances Antiviral Efficacy of HTLV-1-Specific CTLs by Targeting Variant Viruses in HAM Patients. International Journal of Molecular Sciences. 2025; 26(14):6602.
https://doi.org/10.3390/ijms26146602
Chicago/Turabian Style
Kubota, Ryuji, Kousuke Hanada, Mineki Saito, Mika Dozono, Satoshi Nozuma, and Hiroshi Takashima.
2025. "High TCR Degeneracy Enhances Antiviral Efficacy of HTLV-1-Specific CTLs by Targeting Variant Viruses in HAM Patients" International Journal of Molecular Sciences 26, no. 14: 6602.
https://doi.org/10.3390/ijms26146602
APA Style
Kubota, R., Hanada, K., Saito, M., Dozono, M., Nozuma, S., & Takashima, H.
(2025). High TCR Degeneracy Enhances Antiviral Efficacy of HTLV-1-Specific CTLs by Targeting Variant Viruses in HAM Patients. International Journal of Molecular Sciences, 26(14), 6602.
https://doi.org/10.3390/ijms26146602